Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

SIMPLE SUMMARY: Several therapeutic options exist for patients with advanced BRAF-mutant melanoma. Biomarkers able to identify patients with refractory disease or with poor progression-free survival (PFS) and overall survival (OS) expectancy with respect to specific treatments might allow a more per...

Descripción completa

Detalles Bibliográficos
Autores principales: Levati, Lauretta, Bassi, Cristian, Mastroeni, Simona, Lupini, Laura, Antonini Cappellini, Gian Carlo, Bonmassar, Laura, Alvino, Ester, Caporali, Simona, Lacal, Pedro Miguel, Narducci, Maria Grazia, Molineris, Ivan, De Galitiis, Federica, Negrini, Massimo, Russo, Giandomenico, D’Atri, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367338/
https://www.ncbi.nlm.nih.gov/pubmed/35954369
http://dx.doi.org/10.3390/cancers14153706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367338/
https://www.ncbi.nlm.nih.gov/pubmed/35954369
http://dx.doi.org/10.3390/cancers14153706

Ejemplares similares